Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
Pharmacy Department, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Arch Pharm Res. 2024 Mar;47(3):249-271. doi: 10.1007/s12272-023-01481-y. Epub 2023 Dec 26.
Arsenical medicine has obtained its status in traditional Chinese medicine for more than 2,000 years. In the 1970s, arsenic trioxide was identified to have high efficacy and potency for the treatment of acute promyelocytic leukemia, which promoted many studies on the therapeutic effects of arsenic trioxide. Currently, arsenic trioxide is widely used to treat acute promyelocytic leukemia and various solid tumors through various mechanisms of action in clinical practice; however, it is accompanied by a series of adverse reactions, especially cardiac toxicity. This review presents a comprehensive overview of arsenic trioxide from preclinical and clinical efficacy, potential mechanisms of action, toxicities, and rescue strategies for toxicities to provide guidance or assistance for the clinical application of arsenic trioxide.
砷剂在中医药领域已有两千多年的应用历史。20 世纪 70 年代,三氧化二砷被确定对治疗急性早幼粒细胞白血病具有显著疗效和高活性,这促进了许多关于三氧化二砷治疗效果的研究。目前,三氧化二砷通过各种作用机制在临床上广泛用于治疗急性早幼粒细胞白血病和各种实体瘤;然而,它伴随着一系列不良反应,尤其是心脏毒性。本综述从临床前和临床疗效、潜在作用机制、毒性以及毒性的抢救策略等方面对三氧化二砷进行了全面概述,为三氧化二砷的临床应用提供指导或帮助。